Proclear® multifocal toric trials will be discontinued on November 1, 2025, and revenue packs will be discontinued on November 1, 2026.
The contact lens industry continues to evolve, with a strong shift toward silicone hydrogel materials—especially in made-to-order products. To optimize our portfolio and deliver the highest quality lenses to you and your patients, we're updating our product offerings.
What's Changing?
- Proclear® multifocal toric trial lenses will be discontinued on November 1, 2025.
- Proclear® multifocal toric revenue packs will be discontinued on November 1, 2026.
Why Switch to Biofinity®?
Our Biofinity® family of lenses offer a simple fitting upgrade from Proclear® multifocal toric.* With Biofinity® toric multifocal monthly lenses, you'll benefit from:
- Enhanced patient satisfaction†1
- Improved comfort‡2,3
Need Support?
For questions about transitioning patients or product details, please contact your CooperVision Sales Representative or reach out to our Customer Service team at 800-341-2020.
*Seamless refit is: comfort, lens fit, vision performance. ECPs should use fitting guides to ensure selection of appropriate lens parameters including power.
†76% vs. 6%, p<0.005.
‡At 2-week follow-up 80.9±21.6 vs. 73.0±25.0, p=0.04.
1. CVI Data on file, 2018. Non-dispensing, subject masked, randomized, bilateral, cross-over short-term clinical evaluation comparing Biofinity® toric multifocal and Proclear® multifocal toric; n=17.
2. Pucker, A. A Review of Contact Lens Dropout; Clinical Optometry 2020:12 85–94.
3. CVI Data on file, 2017. Subject masked, randomized, bilateral, crossover 2-week dispensing study with Biofinity® toric multifocal and Proclear® multifocal toric; n=24.
18497 08/25